Jagsonpal Pharmaceuticals Ltd.
NSE: JAGSNPHARM | BSE: 507789
₹197.22
₹-3.84
(-1.91%)
As on 19-May-2026IST
Market cap
₹1,327 Cr
Revenue (TTM)
₹287 Cr
P/E Ratio
30.8
P/B Ratio
4.8
Div. Yield
2 %
Quality Score
10/10
Growth Score
6/10
Valuation Score
6/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹43 Cr
-
ROE
28.5 %
-
ROCE
33.1 %
-
Industry P/E
33.65
-
EV/EBITDA
17.4
-
Debt to Equity
0
-
Book Value
₹41.1
-
EPS
₹6.7
-
Face value
2
-
Shares outstanding
67,139,150
10 Years Aggregate
CFO
₹219.26 Cr
EBITDA
₹176.72 Cr
Net Profit
₹159.11 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
| 2.4 | 2.8 | 13.0 | -7.5 | 11.9 | 39.1 | 29.9 |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
| -25.9 | 55.1 | 4.3 | 108.4 | 122.1 | 178.9 | -18.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jagsonpal Pharma
|
197.2 | 1,327.0 | 287.2 | 43.1 | 16.9 | 16.9 | 30.8 | 4.8 |
| 3,248.2 | 40,761.5 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.6 | 9.0 | |
| 557.4 | 1,601.4 | 502.6 | 57.9 | 13.8 | 18.2 | 27.6 | 4.3 | |
| 282.8 | 2,976.9 | 927.1 | 134.7 | 12.8 | 11.2 | 23.1 | 2.5 | |
| 2,038.2 | 15,490.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.2 | 4.3 | |
| 2,171.6 | 34,915.1 | 4,147.8 | 709.5 | 22.3 | 18.3 | 49.2 | 8.4 | |
| 2,000.7 | 2,073.7 | 503.1 | 67.3 | 19.6 | 21.9 | 30.8 | 6.8 | |
| 4,785.4 | 21,873.6 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.3 | 5.2 | |
| 3,230.9 | 7,426.0 | 1,773.8 | 309.8 | 24.0 | 43.1 | 24 | 9.5 | |
| 1,153.6 | 10,633.5 | 4,858.7 | 574.1 | 14.9 | 19.7 | 19.1 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Jagsonpal Pharma
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of... gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India. Read more
-
Incorporated
1978
-
Chairman
Harsha Raghavan
-
Managing Director
Manish Gupta
-
Group
Jagsonpal
-
Headquarters
New Delhi, Delhi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
27-Apr-2026No News & Announcements are available.
FAQs for Jagsonpal Pharma
What is the current share price of Jagsonpal Pharmaceuticals Ltd Today?
The share price of Jagsonpal Pharmaceuticals Ltd is ₹197.22 (NSE) and ₹197.65 (BSE) as of 19-May-2026 IST. Jagsonpal Pharmaceuticals Ltd has given a return of 11.92% in the last 3 years.
What is the current PB & PE ratio of Jagsonpal Pharmaceuticals Ltd?
The P/E ratio of Jagsonpal Pharmaceuticals Ltd is 30.80 times as on 19-May-2026, a 8 discount to its peers’ median range of 33.65 times.
The P/B ratio of Jagsonpal Pharmaceuticals Ltd is 4.80 times as on 19-May-2026, a 5 premium to its peers’ median range of 4.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.90
|
6.58
|
|
2024
|
13.17
|
4.34
|
|
2023
|
11.37
|
5.06
|
|
2022
|
17.43
|
6.19
|
|
2021
|
4.89
|
1.83
|
What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd?
The 52-week high and low of Jagsonpal Pharmaceuticals Ltd are Rs 301.65 and Rs 155.00 as of 19-May-2026.
What is the market cap of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of ₹ 1,327 Cr as on 19-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Jagsonpal Pharmaceuticals Ltd?
Before investing in Jagsonpal Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.